These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9857760)

  • 1. [Pharma-clinics. Drug of the month. Premelle (conjugated estrogens + medroxyprogesterone].
    Scheen AJ
    Rev Med Liege; 1998 Oct; 53(10):638-40. PubMed ID: 9857760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis].
    Wu Y; Liu J; Xing S; Xu R; Zhang Z; Wang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):267-70. PubMed ID: 12133397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of continuous administration of conjugated estrogen plus medroxyprogesterone acetate (Premelle) in postmenopausal women in Taiwan.
    Yang TS; Wang HL; Chen YJ; Chang SP; Yuan CC
    J Chin Med Assoc; 2004 Jul; 67(7):336-43. PubMed ID: 15510930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture?
    Groh KW; Stevermer JJ
    J Fam Pract; 2001 Nov; 50(11):926. PubMed ID: 11711004
    [No Abstract]   [Full Text] [Related]  

  • 5. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
    Hargrove JT; Maxson WS; Wentz AC; Burnett LS
    Obstet Gynecol; 1989 Apr; 73(4):606-12. PubMed ID: 2538787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy should not be used as secondary prevention of coronary heart disease.
    Barbour MM
    Pharmacotherapy; 2000 Sep; 20(9):1021-7. PubMed ID: 10999492
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogen therapy for unstable angina: another bump for the bandwagon.
    Waters DD
    J Am Coll Cardiol; 2002 Jan; 39(2):238-40. PubMed ID: 11788213
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrogen replacement therapy: new options, continuing concerns.
    Hanson RM; Melzer DJ
    JAMA; 1997 May; 277(19):1515; author reply 1515-7. PubMed ID: 9153359
    [No Abstract]   [Full Text] [Related]  

  • 9. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Lobo RA; McCormick W; Singer F; Roy S
    Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does hormone replacement therapy affect disease activity in patients with systemic lupus erythematosus?
    Ramsey-Goldman R
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):72-3. PubMed ID: 16932632
    [No Abstract]   [Full Text] [Related]  

  • 13. Are less than standard doses of hormone replacement therapy (HRT) effective for the treatment of hot flushes?
    Andy C
    J Fam Pract; 2001 Sep; 50(9):743. PubMed ID: 11674902
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone replacement therapy should be administered as secondary prevention of coronary artery disease.
    Spencer AP
    Pharmacotherapy; 2000 Sep; 20(9):1028-33. PubMed ID: 10999493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose hormone replacement therapy for hot flashes.
    Mikhail N
    Mayo Clin Proc; 2003 Mar; 78(3):379; author reply 379. PubMed ID: 12630592
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary on "menopausal hormone treatment in postmenopausal women: risks and benefits".
    Archer DF
    South Med J; 2014 Nov; 107(11):696-7. PubMed ID: 25365436
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
    Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
    N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hormone replacement therapy in endometrial polyp formation.
    Oguz S; Sargin A; Kelekci S; Aytan H; Tapisiz OL; Mollamahmutoglu L
    Maturitas; 2005 Mar; 50(3):231-6. PubMed ID: 15734604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What pharmacists need to know about the women's health initiative estrogen plus progestin trial.
    Saseen JJ; Hansen LB
    Am J Health Syst Pharm; 2003 Feb; 60(3):281-4. PubMed ID: 12613239
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group.
    Fantl JA; Bump RC; Robinson D; McClish DK; Wyman JF
    Obstet Gynecol; 1996 Nov; 88(5):745-9. PubMed ID: 8885906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.